644 filings
Page 26 of 33
EFFECT
f1l 4fovcimkzrqj30g
13 Jul 18
Notice of effectiveness
12:15am
CORRESP
padzdb43gqdmyk4fiog
11 Jul 18
Correspondence with SEC
12:00am
UPLOAD
4eymr9
11 Jul 18
Letter from SEC
12:00am
8-K
auzm1s883geq aqk
3 Jul 18
AzurRx BioPharma Announces Successful Phase IIa Trial of MS1819-SD in Exocrine Pancreatic Insufficiency
12:00am
3
pi1c 3l9w3
4 Jun 18
AzurRx BioPharma / James Pennington ownership change
12:00am
8-K
14zw7s0 b33s
1 Jun 18
AzurRx Announces Appointment of Dr. James Pennington as Chief Medical Officer
5:28pm
SC 13G
d9b3 tdffie
11 May 18
AzurRx BioPharma, Inc.
3:32pm
SC 13G
aset3 zoj
11 May 18
AzurRx BioPharma, Inc.
1:35pm
8-K
z4rjxpkw4
4 May 18
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
12:00am
424B5
vr05fz
2 May 18
Prospectus supplement for primary offering
12:00am
S-3MEF
gc6yzbtwf7omdq1adn2z
1 May 18
Registration of additional securities for an S-3
9:12am
424B5
nxwyufb 4k70kqe9n3c
30 Apr 18
Prospectus supplement for primary offering
12:00am
10-K/A
honvt65dd8
27 Apr 18
Annual report (amended)
12:00am
8-K
lpzr8 9i5lqbtqmmxr0
23 Apr 18
AzurRx BioPharma Announces Positive Preclinical Data with AZX1103
12:00am
8-K
8afdpqyg2 1kp
23 Apr 18
Other Events
12:00am
4
kmmuc5
2 Apr 18
AzurRx BioPharma / Alastair Riddell ownership change
12:00am
4
5wnf42
2 Apr 18
AzurRx BioPharma / EDWARD BORKOWSKI ownership change
12:00am